Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 17, 2013 CD
Six back issues from 2013 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 17 No. 1 January/February 2013 Volume 17, Number 1
Vol. 17 No. 2 March/April 2013 Volume 17, Number 2
Vol. 17 No. 3 May/June 2013 Volume 17, Number 3
Vol. 17 No. 4 July/August 2013 Volume 17, Number 4
Vol. 17 No. 5 September/October 2013 Volume 17, Number 5
Vol. 17 No. 6 November/December 2013 Volume 17, Number 6

Volume 17, 2013 CD ARTICLES

Volume17, 2013 CD ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: How Many Pharmacies Compound and What Do They Compound? Vol. 17 No. 1 4
PreScription: Looking for Solutions Vol. 17 No. 1 4
Pediatric Health Care: An Introduction Vol. 17 No. 1 6
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Vol. 17 No. 1 10
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil? Vol. 17 No. 1 24
Treatment Options for Male Hypogonadism Vol. 17 No. 1 28
Adrenal Fatigue Vol. 17 No. 1 39
International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives Vol. 17 No. 1 48
Quality Control: Analytical Methods: Calibration of Equipment and Calibration Curves Vol. 17 No. 1 50
Basics of Compounding: Repackaging, Part 1 Vol. 17 No. 1 54
Calculations Vol. 17 No. 1 62
Desmopressin 4-mcg/mL Injection Vol. 17 No. 1 64
Dobutamine 10-mg/mL Injection Vol. 17 No. 1 65
Granisetron 1-mg/mL Injection Vol. 17 No. 1 66
Ibuprofen 10-mg/mL Injection Vol. 17 No. 1 67
Mepivacaine Hydrochloride 1% Injection Vol. 17 No. 1 68
Milrinone 0.2-mg/mL Injection Vol. 17 No. 1 69
Neostigmine Methylsulfate 0.5-mg/mL Injection Vol. 17 No. 1 70
Nicardipine Hydrochloride Injection Vol. 17 No. 1 71
Octreotide 50-mcg/mL Injection Vol. 17 No. 1 72
Testosterone Cypionate 100-mg/mL Injection Vol. 17 No. 1 73
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Vol. 17 No. 1 74
Errata Vol. 17 No. 1 86
PostScription: GMPs and GCPs: A Topical Comparison Vol. 17 No. 1 87
PreScription: Pharmacy Committees Vol. 17 No. 2 92
Sterilization of Compounded Parenteral Products: Verification of Autoclaves Vol. 17 No. 2 94
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Vol. 17 No. 2 100
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Vol. 17 No. 2 113
Compounding in Ukraine Vol. 17 No. 2 124
International Academy of Compounding Pharmacists Legislative/Regulatory Update Vol. 17 No. 2 128
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program Vol. 17 No. 2 130
Basics of Compounding: Repackaging, Part 2 Vol. 17 No. 2 136
Calculations Vol. 17 No. 2 142
Adenosine 3-mg/mL Injection Vol. 17 No. 2 144
Alcohol Dehydrated Injection Vol. 17 No. 2 145
Betahistine 16-mg Capsules Vol. 17 No. 2 146
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate Vol. 17 No. 2 147
Cyanocobalamin 1000-mcg/mL Injection Vol. 17 No. 2 148
Dexrazoxane 1-mg/mL Injection Vol. 17 No. 2 149
Meropenem 50-mg/mL Injection Vol. 17 No. 2 150
Paclitaxel 6-mg/mL Injection Vol. 17 No. 2 151
Thiotepa 15-mg/mL Injection Vol. 17 No. 2 152
Verapamil Hydrochloride 2.5-mg/mL Injection Vol. 17 No. 2 153
Compounding Practices and Beliefs of Arizona Pharmacists Vol. 17 No. 2 154
Stability of Rifampin in SyrSpend SF Vol. 17 No. 2 162
Stability of Minoxidil in Espumil Foam Base Vol. 17 No. 2 165
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Vol. 17 No. 2 168
PreScription: Compounding for Drug Shortages Vol. 17 No. 3 180
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Vol. 17 No. 3 182
Decontamination Technology: The Missing Element Vol. 17 No. 3 193
Optimizing Third-party Reimbursement for Compounded Medications Vol. 17 No. 3 201
International Academy of Compounding Pharmacists' Legislative/Regulatory Update Vol. 17 No. 3 206
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Vol. 17 No. 3 210
Basics of Compounding: Potency and Stability Testing Vol. 17 No. 3 220
Calculations Vol. 17 No. 3 226
Buffered Aspirin Capsules Vol. 17 No. 3 228
Calcium Acetate 667-mg Capsules Vol. 17 No. 3 229
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules Vol. 17 No. 3 230
Ethambutol 400-mg Capsules Vol. 17 No. 3 231
Isoniazid 300-mg Capsules Vol. 17 No. 3 232
Labetalol 50-mg Capsules Vol. 17 No. 3 233
Mercaptopurine 75-mg Capsules Vol. 17 No. 3 234
Naltrexone Hydrochloride 50-mg Capsules Vol. 17 No. 3 235
Prednisone 10-mg Capsules Vol. 17 No. 3 236
Reserpine 0.5-mg Capsules Vol. 17 No. 3 237
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Vol. 17 No. 3 238
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Vol. 17 No. 3 247
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Vol. 17 No. 3 254
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial Vol. 17 No. 3 262
Prescription: International Journal of Pharmaceutical Compounding and MEDLINE Update Vol. 17 No. 4 268
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Vol. 17 No. 4 270
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Vol. 17 No. 4 283
Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover Vol. 17 No. 4 290
Types of Pharmacy/Pharmacists Vol. 17 No. 4 294
International Academy of Compounding Pharmacists Legislative/Regulatory Update Vol. 17 No. 4 302
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations Vol. 17 No. 4 307
Basics of Compounding: Foam Dosage Forms Vol. 17 No. 4 312
Calculations Vol. 17 No. 4 324
Acyclovir 20-mg/mL Oral Suspension Vol. 17 No. 4 326
Acyclovir 200-mg Capsules Vol. 17 No. 4 327
Allopurinol Sodium 4-mg/mL Injection Vol. 17 No. 4 328
Amikacin Sulfate 250-mg/mL Injection Vol. 17 No. 4 329
Dacarbazine 200-mg/mL Injection Vol. 17 No. 4 330
Ketamine 50-mg/mL Injection Vol. 17 No. 4 331
Methohexital Sodium 500-mg/mL Injection Vol. 17 No. 4 332
Metoprolol Tartrate 1-mg/mL Injection Vol. 17 No. 4 333
Rifampin 300-mg and Isoniazid 150-mg Capsules Vol. 17 No. 4 334
Succinylcholine Chloride 50-mg/mL Injection Vol. 17 No. 4 335
Stability of Captopril in SyrSPend SF Vol. 17 No. 4 336
Patient-centered Care as Value-added Service by Compounding Pharmacists Vol. 17 No. 4 339
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Vol. 17 No. 4 344
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs Vol. 17 No. 4 347
PostScription: Traditional vs Nontraditional Pharmacy Vol. 17 No. 4 351
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Vol. 17 No. 5 356
Compounding Pharmacies: Before and After an Inspection Vol. 17 No. 5 358
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms Vol. 17 No. 5 364
Chemical Penetration Enhancers Vol. 17 No. 5 370
2013 State Compounding Legislation Tracker Updated: August 12, 2013 Vol. 17 No. 5 375
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease Vol. 17 No. 5 380
Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines Vol. 17 No. 5 384
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Vol. 17 No. 5 388
Quality Control Analytic Methods: Quality Planning, Part 1: A Holistic and Practical Approach Vol. 17 No. 5 393
Basics of Compounding: Basics of Compounding with Tars Vol. 17 No. 5 400
Calculations Vol. 17 No. 5 412
Acyclovir 50-mg/mL Injection Vol. 17 No. 5 414
Aminocaproic Acid 250-mg/mL Injection Vol. 17 No. 5 415
Clindamycin 150-mg/mL Injection Vol. 17 No. 5 416
Fluorouracil 50-mg/mL Injection Vol. 17 No. 5 417
Hydroxyzine Hydrochloride 25-mg/mL Injection Vol. 17 No. 5 418
Indomethacin 1-mg/mL Injection Vol. 17 No. 5 419
Mesna 100-mg/mL Injection Vol. 17 No. 5 420
Methotrexate 25-mg/mL Injection Vol. 17 No. 5 421
Phenylephrine Hydrochloride 10-mg/mL Injection Vol. 17 No. 5 422
Terbutaline Sulfate 1-mg/mL Injection Vol. 17 No. 5 423
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs Vol. 17 No. 5 424
Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment Vol. 17 No. 5 432
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Vol. 17 No. 5 436
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters Vol. 17 No. 5 439
PreScription: Two Milestones for the International Journal of Pharmaceutical Compounding Vol. 17 No. 6 444
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Vol. 17 No. 6 446
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Vol. 17 No. 6 452
Considerations for Pharmacists Working in Major Disaster Areas Vol. 17 No. 6 459
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies Vol. 17 No. 6 465
Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding Vol. 17 No. 6 477
HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now? Vol. 17 No. 6 480
Marketing During the Holidays Vol. 17 No. 6 482
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety Vol. 17 No. 6 485
Basics of Compounding: Basics of Compounding with Balsams Vol. 17 No. 6 490
Calculations Vol. 17 No. 6 496
Benztropine Mesylate 1-mg/mL Injection Vol. 17 No. 6 498
Cefazolin 250-mg/mL Injection Vol. 17 No. 6 499
Ciprofloxacin 250-mg Capsules Vol. 17 No. 6 500
Cortisone Acetate 25-mg Capsules Vol. 17 No. 6 501
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution Vol. 17 No. 6 502
Dihydroergotamine Mesylate 1-mg/mL Injection Vol. 17 No. 6 503
Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate) Vol. 17 No. 6 504
Levothyroxine Sodium 100-mcg Capsules Vol. 17 No. 6 505
Metyrosine 250-mg Capsules Vol. 17 No. 6 506
Phenytoin Sodium 50-mg/mL Injection Vol. 17 No. 6 507
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Vol. 17 No. 6 508
Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds Vol. 17 No. 6 512
Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes Vol. 17 No. 6 515
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream Vol. 17 No. 6 520
PostScription: Augmented Reality for Readers and Authors Vol. 17 No. 6 526